Blood-CNS Barrier Impairment in ALS patients versus an animal model
Open Access
- 1 January 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 8, 21
Abstract
Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease with a compli-cated and poorly understood pathogenesis. Recently, alterations in the blood-Central Nervous System barrier (B-CNS-B) have been recognized as a key factor possibly aggravating motor neuron damage. The majority of findings on ALS microvascular pathology have been deter-mined in mutant SOD1 rodent models, identifying barrier damage during disease develop-ment which might similarly occur in familial ALS patients carrying the SOD1 mutation. However, our knowledge of B-CNS-B competence in sporadic ALS (SALS) has been limited. We recently showed structural and functional impairment in postmortem gray and white mat-ter microvessels of medulla and spinal cord tissue from SALS patients, suggesting pervasive barrier damage. Although numerous signs of barrier impairment (endothelial cell degenera-tion, capillary leakage, perivascular edema, downregulation of tight junction proteins, and microhemorrhages) are indicated in both mutant SOD1 animal models of ALS and SALS pa-tients, other pathogenic barrier alterations have as yet only been identified in SALS patients. Pericyte degeneration, perivascular collagen IV expansion, and white matter capillary abnor-malities in SALS patients are significant barrier related pathologies yet to be noted in ALS SOD1 animal models. In the current review, these important differences in blood-CNS barrier damage between ALS patients and animal models, which may signify altered barrier transport mechanisms, are discussed. Understanding discrepancies in barrier condition between ALS patients and animal models may be crucial for developing effective therapies.Keywords
This publication has 107 references indexed in Scilit:
- Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosisActa Neuropathologica, 2012
- Mechanisms of Dendritic Cell Trafficking Across the Blood–brain BarrierJournal of Neuroimmune Pharmacology, 2011
- Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsyJournal of Neural Transmission, 2011
- Astrogliosis in Amyotrophic Lateral Sclerosis: Role and Therapeutic Potential of AstrocytesNeurotherapeutics, 2010
- The pericyte: Cellular regulator of microvascular blood flowMicrovascular Research, 2009
- Evidence of angiogenic vessels in Alzheimer’s diseaseJournal of Neural Transmission, 2009
- Trans-cellular migration: cell–cell contacts get intimateCurrent Opinion in Cell Biology, 2008
- Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implicationsThe Lancet Neurology, 2007
- Inflammatory processes in amyotrophic lateral sclerosisMuscle & Nerve, 2002
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993